Journal of Urologic Oncology

Search

Page Path

Trimodality Therapy and Immuno-Oncology for Bladder Cancer

Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis: Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, Jongchan Kim, Won Sik Jang, Jee Soo Park, Won Sik Ham; Journal of Urologic Oncology. 2023;21(2):165-173. Published online July 31, 2023; DOI: https://doi.org/10.22465/juo.234600280014
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Effect of Body Mass Index and Hypertension on the Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: Minseung Lee, Sang Hun Song, Hakju Kim, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee, Jong Jin Oh; Korean J Urol Oncol. 2020;18(3):201-208. Published online December 30, 2020; DOI: https://doi.org/10.22465/kjuo.2020.18.3.201; Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

4,535	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
4,198	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
3,714	The Present and Future of Intravesical Therapy in Bladder Cancer
3,446	Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study
3,191	Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?

Cited By 6	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 3	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 2	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By 2	Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com